Perspective Therapeutics Inc. (AMEX: CATX) stock fell -42.01% on Friday to $0.20 against a previous-day closing price of $0.35. With 1.1 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.3 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.3896 whereas the lowest price it dropped to was $0.2050. The 52-week range on CATX shows that it touched its highest point at $0.73 and its lowest point at $0.19 during that stretch. It currently has a 1-year price target of $1.20. Beta for the stock currently stands at 1.62.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CATX was down-trending over the past week, with a drop of -46.74%, but this was down by -48.78% over a month. Three-month performance dropped to -64.01% while six-month performance fell -61.01%. The stock lost -39.71% in the past year, while it has lost -17.04% so far this year.
Float and Shares Shorts:
At present, 279.99 million CATX shares are outstanding with a float of 217.83 million shares on hand for trading. On Aug 30, 2023, short shares totaled 1.57 million, which was 0.56% higher than short shares on Jul 30, 2023. In addition to Mr. Johan M. Spoor as the firm’s CEO & Director, Mr. Jonathan R. Hunt serves as its CFO & Co-Principal Financial Officer.
Institutional Ownership:
Through their ownership of 9.90% of CATX’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 5.92% of CATX, in contrast to 5.83% held by mutual funds. Shares owned by individuals account for 1.64%. As the largest shareholder in CATX with 4.51% of the stake, The Vanguard Group, Inc. holds 12,641,059 shares worth 12,641,059. A second-largest stockholder of CATX, BlackRock Fund Advisors, holds 5,337,782 shares, controlling over 1.90% of the firm’s shares. Perkins Capital Management, Inc. is the third largest shareholder in CATX, holding 2,674,644 shares or 0.95% stake. With a 3.45% stake in CATX, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 9,673,312 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.97% of CATX stock, is the second-largest Mutual Fund holder. It holds 2,710,365 shares valued at 1.1 million. Fidelity Extended Market Index Fu holds 0.50% of the stake in CATX, owning 1,395,292 shares worth 0.57 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, CATX reported revenue of $2.50M and operating income of -$2.11M. The EBITDA in the recently reported quarter was -$2.11M and diluted EPS was -$0.01.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CATX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CATX analysts setting a high price target of $1.20 and a low target of $1.20, the average target price over the next 12 months is $1.20. Based on these targets, CATX could surge 500.0% to reach the target high and rise by 500.0% to reach the target low. Reaching the average price target will result in a growth of 500.0% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded CATX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 5 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 372,904 while 0 shares were sold.
